Erik: Joining me now is Alhambra Investments Chief Investment Officer, Jeffrey Snider.
For newer listeners who are not familiar with Jeff, he’s not only one of our most popular returning guests but he’s well known for his slide decks and the quality of his graphs and charts. So you’re not going to want to miss the slide deck that accompanies today’s interview.
Registered users will find the download link in your Research Roundup email. If you’re not yet registered, just go to our nanjingbb.com 德扑之星app下载home page, click the red button that says Looking for the Downloads? just above Jeff’s picture.
Jeff, for years now we’ve had quite a few other guests on MacroVoices tell us that the dollar was doomed. And the things they usually cite are that the government is printing money like it’s going out of style, reckless spending. And they’re saying eventually this has to lead to debasement of the dollar.
You’ve been the lone voice saying, hey guys, the dollar is just as broken as you think it is, but it’s broken in a very bizarre way where the mechanism for creating more dollars in the international market, the eurodollar system, is not creating dollars the way it’s supposed to. And, ironically, that’s more likely to lead to dollar appreciation, effectively a short squeeze.
For quite a bit of that time, Jeff, you were kind of proven right. Things were going more in the up direction for the dollar than down.
But I think we’ve been here before and we have it again. The dollar index is plumbing multi-year lows. It’s been trading lower ever since May.
Is this the beginning of that long-forecasted dollar crash which would eventually change your thesis?
Erik: Joining me now is David Rosenberg, founder and president of Rosenberg Research.
David, it seems like pretty clearly there’s a light at the end of the pandemic tunnel. At some point in 2021, we’re probably going to have widespread use of a vaccine that hopefully will bring this thing to an end.
So I want to talk about, first, between now and the end of the tunnel it seems like a lot of stuff is getting worse on the pandemic front, at least in the immediate term. Cases and deaths and hospitalizations are up right now. On the other hand, the vaccine is coming.
So how do we reconcile those things? Do we think the market’s already looking past what’s going to happen in the next six months toward the light at the end of the tunnel?
David: Well, I think that the market is looking maybe past the next three months. If you believe the experts, they are going to start to rule out these vaccines any time now and that every American will hopefully – if these positive results from the drug makers have any validity to them, we could be talking about the second half of next year everybody who wants to be inoculated will become inoculated.
Erik: Joining me now is , fund manager, and chief economist for Tressis, Daniel Lecalle.
Daniel, it’s great to have you back on the show. I always look forward to getting your perspective as a European. Here in the United States, we have an interesting situation, which is the presidential election is still contested – although it looks almost certain that Biden will win.
At the same time, we have, on one hand, a great big increase both in the United States and globally in coronavirus infections hospitalizations and deaths. On the other hand, we have two bits of very promising vaccine news, one from Pfizer and just a new one Monday of this week from Moderna.
Stocks rallying to fresh all-time highs, or at least on a closing basis it would be a fresh all-time highs at the numbers we’re seeing right now on the S&P.
What do you make of this? Is it the vaccine that’s doing it? Or was this market just ready to move higher after the election anyway?
Erik: Joining me now is Lakshman Achuthan co-founder of the Economic Cycles Research Institute or ECRI. Lak, it's great to have you back on the show, before we get started listeners, first of all there is a slide deck. You're going to want to download the link it is in your research roundup email, if you don't have a research roundup email just go to our 德扑之星app下载homepage, look for the red button that says looking for the downloads.
Here's the thing I also want you to take to heart Lak was last on the show back in May, we did a lot of coverage of the way that ECRI analyzes cycles, so we talked about the three Ds of every recession, which are depth, diffusion, and duration. We also distinguish the different types of cycles, economic cycles can be growth cycles, they can be business cycles, they can also be inflation cycles. So understanding those differences, all of the content in that May 7th interview is as relevant today as it was the day that it was recorded, we're not going to go back and cover old ground.
So I encourage new listeners, if you don't remember that interview to go back and listen to it because we're going to build on what we started there. Lak, I want to focus on a couple of things you told us in that interview.
Erik: Joining me now is Katusa Research founder Marin Katusa. Marin, it's great to get you back on the show, it's been too long, I just had Professor Stephanie Kelton on a couple of weeks ago and it blew my mind.
We've had more reaction to that interview than anything we've ever done on Macro Voices, and what surprised me was people are angry at me. The sound money crowd is upset, they're like you had the traitor on your show, you've defected. And I'm trying to tell these guys, look, I'm not endorsing this, I'm telling you, you got to get ready for what's coming, like it or not Stephanie Kelton has really one of the most influential voices in public policy and finance right now.
How do you see this? How should gold investors be thinking about MMT? Does it make sense to dismiss it? Or should we take it seriously?